NEW YORK (GenomeWeb News) – Pressure BioSciences and Leap Technologies today said they will co-develop a next-generation sample preparation system for mass spectrometry that combines Pressure Bio's pressure cycling technology and Leap's robotics and lab automation equipment.
The firms will also co-market and co-sell the new system under the terms of the deal announced today. Financial and other terms were not disclosed.
"Because of its clear advantages, mass spectrometry laboratories have begun to integrate PCT into their standard sample preparation workflow, even though the PCT method has not yet been fully automated," Leap CEO Werner Martin said in a statement. "This has created a wonderful opportunity for us to partner with Pressure BioSciences, as we have the experience and expertise to bring automation to their patented PCT Platform."
Pressure Bio President and CEO Richard Schumacher said that his firm has a foothold in the mass spec sample prep arena, "but the ability to build PCT into an automated workflow using Leap's proprietary equipment and software should help us increase our penetration in the mass spectrometry area, and in other areas of the estimated $6 billion life sciences sample preparation market."